| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 11, 2025 | SERA Sera Prognostics, Inc. | Aerts Austin77 | Chief Financial Officer | Sell | 915 | $3.13 | $2,863.95 | -0.3% | +10.7% | - | |
| Sep 11, 2025 | ENOV Enovis Corp | McDonald Damien60 | Chief Executive Officer | Buy | 6,457 | $30.97 | $199,973.29 | +6.7% | -12.4% | - | |
| Sep 11, 2025 | SERA Sera Prognostics, Inc. | Harrison Robert Gardner74 | Chief Information Officer | Sell | 645 | $3.13 | $2,018.85 | -0.6% | +10.7% | - | |
| Sep 11, 2025 | MLSS Milestone Scientific Inc. | Bp4 S.r.l.89 | 10% Owner | Sell | 10,000 | $0.59 | $5,940.00 | -0.1% | -41.6% | - | |
| Sep 11, 2025 | WRBY Warby Parker Inc. | Gilboa David Abraham62 | Co-chief Executive Officer | Sell | 41,040 | $27.53 | $1,129,831.20 | -55.5% | +7.3% | - | |
| Sep 11, 2025 | SERA Sera Prognostics, Inc. | Jackson Benjamin81 | General Counsel | Sell | 934 | $3.13 | $2,923.42 | -0.7% | +10.7% | - | |
| Sep 11, 2025 | ATR Aptargroup, Inc. | Touya Gael61 | Segment President | Sell | 2,500 | $136.12 | $340,297.79 | -3.8% | -14.5% | - | |
| Sep 11, 2025 | BLFS Biolife Solutions Inc | Mathew Aby J.68 | EVP &Chief Scientific Officer | Sell | 630 | $26.83 | $16,902.90 | -0.2% | -7.4% | - | |
| Sep 11, 2025 | WRBY Warby Parker Inc. | Blumenthal Neil Harris65 | Co-chief Executive Officer | Sell | 41,084 | $27.53 | $1,131,042.52 | -55.7% | +7.3% | - | |
| Sep 11, 2025 | IRIX Iridex Corp | Dizon Romeo R64 | Chief Financial Officer | Buy | 1,250 | $1.35 | $1,682.20 | +0.7% | -31.5% | - | |
| Sep 11, 2025 | ZBH Zimmer Biomet Holdings, Inc. | Yi Sang62 | Group President, Asia Pacific | Sell | 1,200 | $103.59 | $124,302.00 | -6.1% | -10.7% | - | |
| Sep 11, 2025 | SERA Sera Prognostics, Inc. | Kearney Paul78 | Chief Data Officer | Sell | 1,271 | $3.13 | $3,978.23 | -0.7% | +10.7% | - | |
| Sep 11, 2025 | BLFS Biolife Solutions Inc | Foster Karen A.67 | Chief Quality And Operations | Sell | 511 | $26.83 | $13,710.13 | -0.3% | -7.4% | - | |
| Sep 11, 2025 | ELMD Electromed, Inc. | Summers Andrew79 | Director | Sell | 65,714 | $24.32 | $1,598,453.61 | -60.3% | +16.3% | - | |
| Sep 10, 2025 | BDX Becton Dickinson & Co | Fraser Claire55 | Director | Sell | 917 | $187.50 | $171,937.50 | -4.0% | +0.8% | - | |
| Sep 10, 2025 | IRIX Iridex Corp | Dizon Romeo R64 | Chief Financial Officer | Buy | 1,500 | $1.34 | $2,010.00 | +1.3% | -30.7% | - | |
| Sep 10, 2025 | RGEN Repligen Corp | Hunt Anthony75 | Director | Sell | 29,111 | $120.52 | $3,508,388.91 | -4.0% | +33.6% | - | |
| Sep 10, 2025 | PLSE Pulse Biosciences, Inc. | Duggan Robert W76 | Director, 10% Owner | Buy | 192,599 | $14.48 | $2,788,624.34 | +0.1% | -7.3% | - | |
| Sep 10, 2025 | AZTA Azenta, Inc. | Marotta John | President And CEO | Sell | 316 | $29.41 | $9,293.56 | -0.3% | +21.6% | - | |
| Sep 9, 2025 | ATEC Alphatec Holdings, Inc. | Berkowitz Mortimer III | Director | Sell | 62,500 | $15.97 | $998,125.00 | -9.2% | +32.7% | - | |
| Sep 9, 2025 | LAB Standard Biotools Inc. | Casdin Partners Master Fund, L.P.53 | Director, 10% Owner | Buy | 100,000 | $1.29 | $128,920.00 | +0.2% | +14.1% | - | |
| Sep 9, 2025 | SERA Sera Prognostics, Inc. | Lawrence Sandra Aj54 | Director | Sell | 3,899 | $3.05 | $11,891.95 | -17.2% | -1.6% | - | |
| Sep 9, 2025 | SERA Sera Prognostics, Inc. | Lindgardt Zhenya75 | Chief Executive Officer | Sell | 21,158 | $3.15 | $66,647.70 | -2.5% | -1.6% | - | |
| Sep 9, 2025 | IRIX Iridex Corp | Dizon Romeo R64 | Chief Financial Officer | Buy | 1,500 | $1.37 | $2,055.00 | +2.7% | -32.0% | - | |
| Sep 9, 2025 | SERA Sera Prognostics, Inc. | Aerts Austin77 | Chief Financial Officer | Sell | 5,263 | $3.15 | $16,578.45 | -1.8% | -1.6% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.